Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elevit Breastfeeding Supplementation Effects
NCT04462939Completed
- Sponsor
- Bayer
- Start
- Apr 2017
- Primary completion
- Nov 2019
- Countries
- 1
01
Overview
Randomised, double-blind trial (2 arms), sponsored by Bayer. Primary endpoint: Change from baseline in human milk total lipid docosahexaenoic acid (DHA) content at 12 weeks. Started Apr 2017; status: completed.
Beyond the preview
Go deeper on NCT04462939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04462939.